Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment

Citation
G. Brock et al., Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment, UROLOGY, 57(3), 2001, pp. 536-541
Citations number
17
Categorie Soggetti
Urology & Nephrology
Journal title
UROLOGY
ISSN journal
00904295 → ACNP
Volume
57
Issue
3
Year of publication
2001
Pages
536 - 541
Database
ISI
SICI code
0090-4295(200103)57:3<536:ROSEDL>2.0.ZU;2-2
Abstract
Objectives. To investigate the effect of long-term intracavernosal self-inj ection of alprostadil (Caverject) on the penile circulation and return of s pontaneous erection in men with arteriogenic erectile dysfunction. Methods. Seventy men with a stable heterosexual partner entered the titrati on phase of this open-label, flexible-dose study. The effective alprostadil dose (ie, the dose producing penile rigidity adequate for intercourse and lasting up to 60 minutes) was determined before entry into the 12-month sel f-treatment home phase. Duplex ultrasonography was used to measure the peak systolic velocity and diameter of the cavernosal arteries at the end of th e titration phase and after 4, 8, and 12 months of the home phase. The effi cacy, tolerability, and return of spontaneous erections were assessed from the patients' diaries and by interview at each clinic visit. Sixty-three me n entered the home phase; 49 of them filled out the diaries and 42 complete d the study. Results. An effective dose was established for 67 (96%) of the 70 men (medi an dose 15 mug). During the home phase, 94% of men responded to alprostadil , and the median dose remained unchanged. Complete duplex ultrasound data w ere obtained in 38 men and showed significant increases in postinjection pe ak systolic velocity in both cavernosal arteries (P < 0.001 at 12 months) a nd between the preinjection and postinjection cavernosal arterial diameters (P = 0.0001) compared with baseline. Reports of a return of spontaneous er ections increased throughout the study compared with baseline (37%, 26 of 7 0) and were confirmed by interview for 46 (85%) of 54 men with available da ta overall. Treatment was generally well accepted, with low incidences of p enile pain (23%), prolonged erection. which resolved spontaneously (6%), an d fibrosis (1%). Conclusions. Intracavernosal alprostadil was effective, acceptable, and gen erally well tolerated in men with arteriogenic erectile dysfunction. Long-t erm treatment improved the penile circulation, and most men reported an inc rease in return of spontaneous erections. UROLOGY 57: 536-541, 2001. (C) 20 01, Elsevier Science Inc.